Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31,260 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prostate cancer in Asia: A collaborative report.
Chen R, Ren S; Chinese Prostate Cancer Consortium; Yiu MK, Fai NC, Cheng WS, Ian LH, Naito S, Matsuda T, Kehinde E, Kural A, Chiu JY, Umbas R, Wei Q, Shi X, Zhou L, Huang J, Huang Y, Xie L, Ma L, Yin C, Xu D, Xu K, Ye Z, Liu C, Ye D, Gao X, Fu Q, Hou J, Yuan J, He D, Pan T, Ding Q, Jin F, Shi B, Wang G, Liu X, Wang D, Shen Z, Kong X, Xu W, Deng Y, Xia H, Cohen AN, Gao X, Xu C, Sun Y. Chen R, et al. Among authors: zhou l. Asian J Urol. 2014 Oct;1(1):15-29. doi: 10.1016/j.ajur.2014.08.007. Epub 2015 Apr 16. Asian J Urol. 2014. PMID: 29511634 Free PMC article.
Asian trends in prostate cancer hormone therapy.
Akaza H, Naito S, Cheng C, Kaisary A, Soebadi DM, Umbas R, Esuvaranathan K, Gu FL, Zhou L, Hong SJ, Kim WJ, Lee SE, Rim JS, Song JM, Yoon JH, Chang SJ, Huang CH, Yang CR, Hirao Y, Murai M, Tsukamoto T, Usami M. Akaza H, et al. Among authors: zhou l. Gan To Kagaku Ryoho. 2002 Nov;29(11):1951-61. Gan To Kagaku Ryoho. 2002. PMID: 12465395
The 2nd conference on Asian trends in prostate cancer hormone therapy.
Akaza H, Chang SJ, Chen KK, Esuvaranathan K, Fujioka T, Hirao Y, Hong SJ, Hinotsu S, Kim WJ, Lau W, Lee SE, Murai M, Naito S, Ogawa O, Rim JS, Soebadi DM, Song JM, Tsukamoto T, Umbas R, Usami M, Yang CR, Yoon JH, Zhou L. Akaza H, et al. Among authors: zhou l. Gan To Kagaku Ryoho. 2003 Oct;30(10):1533-42. Gan To Kagaku Ryoho. 2003. PMID: 14584292
The 3rd Conference on Asian Trends in Prostate Cancer Hormone Therapy.
Akaza H, Naito S, Chang SJ, Chen KK, Cheng C, Choi HY, Fujioka T, Hinotsu S, Hirao Y, Hong SJ, Kim CS, Kim WJ, Lee SE, Murai M, Ogawa O, Rim JS, Soebadi DM, Song JM, Tsukamoto T, Umbas R, Usami M, Xia S, Yang CR, Yoon JH, Zhou L. Akaza H, et al. Among authors: zhou l. Gan To Kagaku Ryoho. 2004 Aug;31(8):1285-95. Gan To Kagaku Ryoho. 2004. PMID: 15332559
Prostate Cancer Working Group report.
Namiki M, Akaza H, Lee SE, Song JM, Umbas R, Zhou L, Lee BC, Cheng C, Chung MK, Fukagai T, Hinotsu S, Horie S. Namiki M, et al. Among authors: zhou l. Jpn J Clin Oncol. 2010 Sep;40 Suppl 1:i70-75. doi: 10.1093/jjco/hyq130. Jpn J Clin Oncol. 2010. PMID: 20870924
Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(-1).
Chen R, Zhou LQ, Cai XB, Xie LP, Huang YR, He DL, Gao X, Xu CL, Ding Q, Wei Q, Yin CJ, Ren SC, Wang FB, Tian Y, Sun ZQ, Fu Q, Ma LL, Zheng JH, Ye ZQ, Ye DW, Xu DF, Hou JQ, Xu KX, Yuan JL, Gao X, Liu CX, Pan TJ, Sun YH; Chinese Prostate Cancer Consortium. Chen R, et al. Asian J Androl. 2015 Nov-Dec;17(6):1017-21. doi: 10.4103/1008-682X.150846. Asian J Androl. 2015. PMID: 25926603 Free PMC article.
Age-Specific Cutoff Value for the Application of Percent Free Prostate-Specific Antigen (PSA) in Chinese Men with Serum PSA Levels of 4.0-10.0 ng/ml.
Chen R, Huang Y, Cai X, Xie L, He D, Zhou L, Xu C, Gao X, Ren S, Wang F, Ma L, Wei Q, Yin C, Tian Y, Sun Z, Fu Q, Ding Q, Zheng J, Ye Z, Ye D, Xu D, Hou J, Xu K, Yuan J, Gao X, Liu C, Pan T, Sun Y; Chinese Prostate Cancer Consortium. Chen R, et al. Among authors: zhou l. PLoS One. 2015 Jun 19;10(6):e0130308. doi: 10.1371/journal.pone.0130308. eCollection 2015. PLoS One. 2015. PMID: 26091007 Free PMC article.
Enhanced recovery after surgery for radical cystectomy with ileal urinary diversion: a multi-institutional, randomized, controlled trial from the Chinese bladder cancer consortium.
Lin T, Li K, Liu H, Xue X, Xu N, Wei Y, Chen Z, Zhou X, Qi L, He W, Tong S, Jin F, Liu X, Wei Q, Han P, Gou X, He W, Zhang X, Yang G, Shen Z, Xu T, Xie X, Xue W, Cao M, Yang J, Hu J, Chen F, Li P, Li G, Xu T, Tian Y, Wang W, Song D, Shi L, Yang X, Yang Y, Shi B, Zhu Y, Liu X, Xing J, Wu Z, Zhang K, Li W, Liang C, Yang C, Li W, Qi J, Xu C, Xu W, Zhou L, Cai L, Xu E, Cai W, Weng M, Su Y, Zhou F, Jiang L, Liu Z, Chen Q, Pan T, Liu B, Zhou Y, Gao X, Qiu J, Situ J, Hu C, Chen S, Zheng Y, Huang J. Lin T, et al. Among authors: zhou x, zhou y, zhou f, zhou l. World J Urol. 2018 Jan;36(1):41-50. doi: 10.1007/s00345-017-2108-3. Epub 2017 Oct 28. World J Urol. 2018. PMID: 29080948 Clinical Trial.
31,260 results
You have reached the last available page of results. Please see the User Guide for more information.